Ipsen is a global biopharmaceutical company, improving patients’ lives through research and innovation in oncology, rare disease and neuroscience.
Ipsen is a global leader in neuroscience and toxins research for neuromuscular treatments. Neuroscience is advancing at an unprecedented rate, and we are proud to be at the forefront of this transformation. Our focus is on enabling children and adults suffering from debilitating and degenerative neuromuscular disorders. Our long‐term commitment to advancing neuroscience and toxins research is evidenced by 30 years of clinical experience.
Visit our website: https://www.ipsen.com/
Click here to view Ipsen activities during ISPRM 2024.
